Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Dynatrace 25M share Secondary priced at $34.50 » 20:09
02/20/20
02/20
20:09
02/20/20
20:09
DT

Dynatrace

$35.33 /

+0.24 (+0.68%)

The deal priced below…

The deal priced below last closing price of $35.39. Goldman Sachs, JPMorgan and Citi are acting as joint book running managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21
    Feb
Tuesday
Syndicate
Dynatrace files to sell 25M shares of common stock » 16:17
02/18/20
02/18
16:17
02/18/20
16:17
DT

Dynatrace

$35.11 /

-1.1 (-3.04%)

Goldman Sachs, JPMorgan…

Goldman Sachs, JPMorgan and Citigroup are acting as lead bookrunning managers for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Downgrade
New Relic downgraded to Market Perform from Outperform at BMO Capital » 05:00
02/05/20
02/05
05:00
02/05/20
05:00
NEWR

New Relic

$70.81 /

+2.95 (+4.35%)

, DT

Dynatrace

$32.44 /

+2.21 (+7.31%)

BMO Capital analyst Keith…

BMO Capital analyst Keith Bachman downgraded New Relic (NEWR) to Market Perform from Outperform with a price target of $72, down from $78. The analyst is "dubious" on New Relic's improving revenue or annual recurring revenue growth following last night's results. Further, having fiscal 2021 as an investment year will keep the stock range-bound, Bachman tells investors in a research note. The analyst prefers shares of Dynatrace (DT) over New Relic.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Largest borrow rate increases among liquid names » 08:45
02/04/20
02/04
08:45
02/04/20
08:45
GTT

GTT Communications

$12.54 /

+0.69 (+5.82%)

, RVLV

Revolve Group

$17.44 /

-0.37 (-2.08%)

, TRIL

Trillium Therapeutics

$4.10 /

+0.295 (+7.75%)

, HIIQ

Health Insurance Innovations

$23.24 /

+0.25 (+1.09%)

, EEM

iShares MSCI Emerging Markets ETF

$42.56 /

+0.43 (+1.02%)

, CGC

Canopy Growth

$22.11 /

-0.42 (-1.86%)

, CBOE

Cboe Global Markets

$123.70 /

+0.41 (+0.33%)

, SPCE

Virgin Galactic

$18.58 /

+1.43 (+8.34%)

, MLNX

Mellanox

$119.95 /

-0.99 (-0.82%)

, DT

Dynatrace

$30.23 /

-1.1 (-3.51%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: GTT Communications (GTT) 87.69% +2.85, Revolve Group (RVLV) 59.46% +1.19, Trillium Therapeutics (TRIL) 32.96% +0.84, Health Insurance Innovations (HIIQ) 11.33% +0.41, iShares Emerging Markets ETF (EEM) 0.49% +0.24, Canopy Growth (CGC) 57.24% +0.20, CBOE Holdings (CBOE) 0.43% +0.18, Virgin Galactic (SPCE) 14.01% +0.17, Mellanox (MLNX) 0.42% +0.17, and Dynatrace (DT) 0.39% +0.12.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dynatrace price target raised to $40 from $35 at BMO Capital » 08:46
01/30/20
01/30
08:46
01/30/20
08:46
DT

Dynatrace

/

+

BMO Capital analyst Keith…

BMO Capital analyst Keith Bachman raised his price target on Dynatrace to $40 and kept his Outperform rating after its "strong" Q3 results featuring upside in revenue, margins, and ARR. The analyst is positive on the company's "comprehensive monitoring platform with proven scalability in the large enterprise" and continues to expect durable revenue and ARR growth with further customer expansion and new logo wins.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dynatrace price target raised to $37 from $28 at Citi » 06:59
01/30/20
01/30
06:59
01/30/20
06:59
DT

Dynatrace

$30.98 /

+2.31 (+8.06%)

Citi analyst Walter…

Citi analyst Walter Pritchard raised his price target for Dynatrace to $37 from $28 saying the company's annual recurring revenue and customer growth drove the upside in Q3 and supports a stronger outlook for Q4. The analyst views Dynatrace as the best way to gain exposure to the front and back end monitoring market. He keeps a Buy rating on the shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dynatrace price target raised to $31 from $25 at Jefferies » 05:23
01/30/20
01/30
05:23
01/30/20
05:23
DT

Dynatrace

$30.98 /

+2.31 (+8.06%)

Jefferies analyst Brent…

Jefferies analyst Brent Thill raised his price target for Dynatrace to $31 from $25 saying the company's fiscal Q3 results beat estimates across the board and its fiscal 2020 guidance was raised. The analyst expects 30%-plus total annual recurring revenue growth in fiscal 2021 but keeps a Hold rating on the shares due to valuation.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: Pre-market Movers » 09:03
01/29/20
01/29
09:03
01/29/20
09:03
GE

General Electric

$11.73 /

+0.29 (+2.53%)

, BA

Boeing

$316.62 /

+0.01 (+0.00%)

, AAPL

Apple

$317.76 /

+8.83 (+2.86%)

, LB

L Brands

$20.56 /

+0.36 (+1.78%)

, SRNE

Sorrento Therapeutics

$4.03 /

+0.14 (+3.60%)

, MA

MasterCard

$320.27 /

+4.59 (+1.45%)

, DT

Dynatrace

$28.67 /

+0.76 (+2.72%)

, MCD

McDonald's

$210.48 /

+1.06 (+0.51%)

, ADP

ADP

$178.32 /

+2.48 (+1.41%)

, ANTM

Anthem

$290.71 /

+7.03 (+2.48%)

, HES

Hess Corp.

$62.07 /

-0.08 (-0.13%)

, EBAY

eBay

$36.22 /

+0.74 (+2.09%)

, AMD

AMD

$50.51 /

+1.25 (+2.54%)

, BHVN

Biohaven Pharmaceutical

$56.32 /

+3.015 (+5.66%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: General Electric (GE), up 8%... Boeing (BA), up 2%... Apple (AAPL), up 2%... MasterCard (MA), up 1%... Dynatrace (DT), up 6%. ALSO HIGHER: L Brands (LB), up 12% after the Wall Street Journal reports Leslie Wexner is in talks to step aside as CEO of the company and it is also exploring strategic alternatives for Victoria's Secret... Sorrento Therapeutics (SRNE), up 5% after initiating a clinical and manufacturing collaboration with Celularity. DOWN AFTER EARNINGS: ADP (ADP), down 3%... Anthem (ANTM), down 3%... eBay (EBAY), down 4%... AMD (AMD), down 5%. ALSO LOWER: Biohaven Pharmaceutical (BHVN), down 10% after filing to sell $250M of common stock.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29
    Jan
Earnings
Dynatrace sees FY20 non-GAAP EPS 28c, consensus 24c » 06:07
01/29/20
01/29
06:07
01/29/20
06:07
DT

Dynatrace

$28.67 /

+0.76 (+2.72%)

Sees FY20 revenue…

Sees FY20 revenue $542.2M-$542.2M, consensus $534.33M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Dynatrace sees Q4 non-GAAP EPS 8c, consensus 7c » 06:06
01/29/20
01/29
06:06
01/29/20
06:06
DT

Dynatrace

$28.67 /

+0.76 (+2.72%)

Sees Q4 revenue…

Sees Q4 revenue $147.0M-$148.0M, consensus $144.86M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.